Sarepta Therapeutics logo

Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy

Sarepta Therapeutics

Cambridge, MA; North Carolina, US; New Jersey, US; Virginia, US; Maine, US; Rhode Island, US; Washington, DC; Florida, US; New York, US; Illinois, US; Connecticut, US; New Hampshire, USHybridPosted 2 days ago$185,600 - $232,000 per year
Full TimeDirector & AboveClinical DevelopmentBiotechnology
Original posting ↗

Summary

The Director of Quantitative & Clinical Pharmacology will be responsible to lead clinical pharmacology and pharmacometrics deliverables from early through late-stage clinical development (Ph3 and product registration), with an emphasis on clinical dose selection/refinement and predictive PK/PD modeling inclusive of population and statistically-based methodologies, as well as mechanistic and translational-focused approaches. This is a highly visible and team-facing role.

Job description

The Importance of the Role

The Director of Quantitative & Clinical Pharmacology will be responsible to lead clinical pharmacology and pharmacometrics deliverables from early through late-stage clinical development (Ph3 and product registration), with an emphasis on clinical dose selection/refinement and predictive PK/PD modeling inclusive of population and statistically-based methodologies, as well as mechanistic and translational-focused approaches. This is a highly visible and team-facing role.

The Opportunity to Make a Difference

  • Drives the development and execution of the quantitative pharmacology strategies across all stages of drug development through product registration
  • Leads clinical pharmacology expertise in clinical and translational development strategies, protocol preparation, study execution, data review/analysis, study reports
  • Responsible for model-based data analyses including population PK, PK/PD modeling and simulation, meta-analysis, disease modeling to inform clinical development
  • Serves as functional lead for global regulatory strategies and HA engagements
  • Maintains leading-edge knowledge in clinical pharmacology and pharmacometrics discipline, publishes manuscripts, presents at scientific conferences and scientific forums

More about You

  • PhD in Pharmaceutical Sciences, mathematics/engineering or related field with 7 years of experience working in clinical pharmacology or pharmacometrics
  • Strong understanding of clinical pharmacology principles, strong hands-on experience with PK/PD modeling analysis, and experience in regulatory interactions
  • Excellent communication, multitasking, and collaboration skills
  • Experience in NONMEM & R highly preferred
  • siRNA and/or CNS experience is preferred

Requirements

  • PhD in Pharmaceutical Sciences, mathematics/engineering or related field
  • 7 years of experience working in clinical pharmacology or pharmacometrics
  • Strong understanding of clinical pharmacology principles
  • Strong hands-on experience with PK/PD modeling analysis
  • Experience in regulatory interactions
  • Excellent communication, multitasking, and collaboration skills
  • Experience in NONMEM & R highly preferred
  • siRNA and/or CNS experience is preferred
  • Candidates must be authorized to work in the U.S.

Benefits

  • Physical and Emotional Wellness
  • Financial Wellness
  • Support for Caregivers

Company overview

Sarepta Therapeutics is a global biotechnology company headquartered in Cambridge, Massachusetts, focused on developing precision genetic medicines for rare diseases. Founded in 1980, the company has evolved into a commercial-stage biopharmaceutical leader with a specialized focus on RNA-based therapeutics and gene therapies. Sarepta's primary mission centers on treating devastating rare genetic disorders, particularly Duchenne muscular dystrophy (DMD), a progressive muscle-wasting disease affecting children. The company has developed multiple FDA-approved treatments including Exondys 51, Amondys 45, Vyondys 53, and the groundbreaking gene therapy ELEVIDYS. Sarepta employs approximately 1,300-1,400 professionals and maintains research facilities across multiple locations. The company's scientific platform leverages Morpholino oligomer technology for exon-skipping therapies and advanced adeno-associated virus (AAV) vectors for gene therapy delivery. With a market capitalization exceeding $2 billion, Sarepta continues to expand its pipeline to address additional rare diseases while building the world's largest gene therapy manufacturing capacity to accelerate patient access to transformative treatments.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.